| HR | HR 95% confidence interval | P-value |
---|---|---|---|
Training set | Â | Â | Â |
ER status | 1.32 | 0.62-2.84 | 0.470 |
TP53 mutation | 1.08 | 0.48-2.45 | 0.850 |
T status (2) | 2.14 | 0.89-5.13 | 0.088 |
T status (3 or 4) | 1.48 | 0.47-4.59 | 0.502 |
Lymph node status | 2.22 | 0.89-5.51 | 0.087 |
Prognostic signature | 29.0 | 9.36-89.9 | 5.4E-09 |
TCGA validation | Â | Â | Â |
ER status | 0.87 | 0.49-1.55 | 0.639 |
T status (2) | 0.92 | 0.47-1.82 | 0.814 |
T status (3 or 4) | 1.14 | 0.51-2.54 | 0.749 |
Lymph node status | 2.13 | 1.14-3.98 | 0.018 |
Prognostic signature | 2.09 | 1.21-3.59 | 0.008 |